Sydney, Apr 21, 2006 (ABN Newswire) - HeartWare (ASX: HTW) is pleased to announce the appointment of Mr Dozier Rowe as Chief Operating Officer, based at HeartWare's operations centre in Miramar, Florida.

Dozier brings to HeartWare over 25 years of experience in the medical device industry, having held senior positions at Boston Scientific Corporation, St Jude Medical Inc. and Baxter Healthcare Corporation. He has worked with a variety of Class III implantable medical devices, with responsibility across all elements of manufacturing, quality control, regulatory affairs, materials management, supply chain and operations. Prior to establishing his own manufacturing consulting company in 2004, Dozier held the position of Vice President and General Manager, Operations at Boston Scientific's Miami operations centre, where he had responsibility for over 1,000 staff and a budget in excess of USD100 million per year.

Reporting directly to HeartWare's Chief Executive Officer, Dozier assumes primary responsibility for managing and leading all internal operational functions of the business.

HeartWare CEO, Mr Stuart McConchie, commented:
"Having recently commenced human clinical studies for the HVAD, HeartWare is transitioning from a product development organisation into a manufacturer of Class III medical devices. Dozier Rowe's depth of industry experience will be invaluable as we scale up our manufacturing capabilities to meet the anticipated clinical demand."